Solvay（SOLB）株式概要
ソルベイSAは、基礎化学品と機能化学品を世界中に提供している。 詳細
SOLB Community Fair Values
Create NarrativeSee what 46 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
ST
stuart_roberts
Community ContributorCA$5.07FV • 68.0% 割安 内在価値ディスカウント
4849.4%Revenue growth p.a.
13.5k
37
1
271
Solvay SA 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | €27.90 |
| 52週高値 | €34.52 |
| 52週安値 | €23.54 |
| ベータ | 0.24 |
| 1ヶ月の変化 | 4.49% |
| 3ヶ月変化 | 10.98% |
| 1年変化 | -17.75% |
| 3年間の変化 | -74.12% |
| 5年間の変化 | -75.19% |
| IPOからの変化 | 0.49% |
最新ニュース
SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value
Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value
Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades
Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.Recent updates
SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value
Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value
Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades
Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.SOLB: Rare Earth Supply Role Will Offset Softer Outlook And Downgrades
Analysts have reduced their price target on Solvay to about €25.88 from roughly €26.44, reflecting a series of recent downgrades and slightly softer assumptions for revenue, margins and fair value multiples. Analyst Commentary Bullish Takeaways Bullish analysts still see upside to the current share price, with some targets such as €28 and €27 implying room for rerating if execution on cost discipline and portfolio focus holds up.SOLB: Rare Earth Partnerships Will Counter Softer Outlook And Cautious Ratings
Analysts have trimmed their price targets on Solvay, with our fair value estimate moving from €27.19 to €26.44 as they factor in slightly softer revenue expectations, a higher discount rate, and lower assumed future P/E multiples, partly offset by firmer profit margin assumptions. Analyst Commentary Recent Street research on Solvay has leaned more cautious, with several firms lowering price targets and moving to more neutral or negative ratings as they reassess the risk and reward profile.SOLB: Rare Earth Agreements Will Offset Softer Outlook At A Fair Price
Analysts have nudged their Solvay price target slightly lower to about €27.19 from about €27.27, reflecting updated views on slower revenue trends, a higher discount rate, better profit margins, and a lower future P/E assumption, alongside recent target cuts and rating changes from several research houses. Analyst Commentary Recent research opinions around Solvay cluster around cautious updates to price targets and ratings, with most commentary focusing on how current execution and growth expectations line up against existing valuations.SOLB: Rare Earth Agreements Will Steady Execution Risks At A Fair Price
Analysts have trimmed their price target on Solvay to about €23.50, a modest reset that reflects slightly lower profit margin expectations while keeping fair value and P/E assumptions broadly in line with prior views. Analyst Commentary Recent research points to a slightly lower fair value marker for Solvay at about €23.50, which still sits close to prior assumptions on P/E and overall valuation.SOLB: Rare Earth Agreements Will Offset Softer Outlook And Heightened Execution Risks
Analysts trimmed their fair value estimate for Solvay by about EUR 0.50 per share, reflecting slightly higher perceived risk and softer long term growth expectations, in line with a series of recent price target cuts across the Street. Analyst Commentary Recent Street updates reflect a cautious stance on Solvay, with a series of modest price target reductions signaling tempered expectations for both earnings growth and valuation upside.SOLB: Near-Term Outlook Will Hinge On Margin Resilience Amid Industry Pressures
Solvay’s analyst price target was modestly reduced from €27.80 to €27.73. Analysts cite ongoing cautiousness around revenue growth and margin pressures, which are reflected in several recent downward revisions.SOLB: Future Performance Will Depend On Profit Margin Recovery And Cost Discipline
Solvay's analyst price target was reduced from €28.70 to €27.80, as analysts cited a more cautious outlook on revenue growth and profit margins in recent research updates. Analyst Commentary Analyst sentiment toward Solvay has shifted in recent research updates, with several firms lowering their price targets and highlighting both positive and negative drivers that could influence the company’s near-term performance.SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals
Narrative Update on Solvay Solvay’s analyst price target has been lowered slightly, from €28.97 to €28.70, as analysts cite modestly higher discount rates and slightly weaker revenue growth outlooks in their recent updates. Analyst Commentary Recent updates from analysts have provided a nuanced view of Solvay's outlook, highlighting both areas of potential and ongoing challenges that may affect its future performance.La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have modestly reduced their price target for Solvay, lowering it by a small margin in response to recent Street research. The research cites softer profit margins and ongoing revenue pressures, resulting in updated targets between EUR 25.50 and EUR 27.La Rochelle Expansion And Energy Transition Will Secure Future Success
Solvay's analyst price target has been revised downward by approximately EUR 0.80 per share. Analysts cite ongoing revenue pressure and updated profit margin forecasts to support the adjustment.La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have maintained a cautious outlook on Solvay due to persistent input cost inflation, margin pressure, and weak European demand, resulting in conservative earnings estimates and an unchanged consensus price target of €29.83. Analyst Commentary Cautious sentiment persists due to slower organic growth outlook in core businesses.Risks To Shareholder Returns Are Elevated At These Prices For Solvay SA (EBR:SOLB)
Jan 24
Solvay (EBR:SOLB) Will Pay A Dividend Of €0.679
Jan 06
Green River Expansion And Hydrogen Peroxide Licensing Propel Earnings Growth
Expansion of Green River facility and sustainability efforts position Solvay to benefit from future revenue growth and attract environmentally conscious customers.Solvay's (EBR:SOLB) Dividend Will Be €0.679
Dec 21Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Oct 17Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?
Sep 18Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk
Aug 28Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point
Aug 08Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet
Jul 14Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Jun 14Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
May 29Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Apr 24Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Mar 10Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Nov 20Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Nov 06The Return Trends At Solvay (EBR:SOLB) Look Promising
Nov 02Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Oct 19Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
Aug 16Returns At Solvay (EBR:SOLB) Are On The Way Up
Aug 02Is Solvay (EBR:SOLB) A Risky Investment?
Jul 19An Intrinsic Calculation For Solvay SA (EBR:SOLB) Suggests It's 26% Undervalued
Jul 06株主還元
| SOLB | BE Chemicals | BE 市場 | |
|---|---|---|---|
| 7D | 1.5% | 1.1% | 0.9% |
| 1Y | -17.7% | 0.4% | 18.0% |
業界別リターン: SOLB過去 1 年間で0.4 % の収益を上げたBelgian Chemicals業界を下回りました。
リターン対市場: SOLBは、過去 1 年間で18 % のリターンを上げたBelgian市場を下回りました。
価格変動
| SOLB volatility | |
|---|---|
| SOLB Average Weekly Movement | 4.1% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in BE Market | 7.4% |
| 10% least volatile stocks in BE Market | 2.6% |
安定した株価: SOLB 、 Belgian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: SOLBの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1863 | 8,331 | Philippe Kehren | www.solvay.com |
ソルベイSAは基礎化学品と機能化学品を世界中に提供している。建築用ガラス、ソーラーパネル、ガラス容器、包装、電気自動車用リチウムイオン電池、洗剤や化学薬品に使用される炭酸ナトリウムやソーダ灰、食品・飼料、排ガス処理、ヘルスケアに使用される炭酸水素ナトリウムの製造を行っている。また、パルプ・製紙、繊維、水、食品、半導体、太陽光発電、都市鉱山、電池などの産業で漂白、除染、消毒、防腐の目的で使用される過酸化水素、プロピレンオキシドやカプロラクタムなどの化学品を製造する中間体としての過酸化水素も提供している。さらに、タイヤ、ホームケア、飼料、食品産業での用途に不可欠な成分である沈殿シリカや、絵画、衛生、ホームケア用途に使用される溶剤やポリアミドチェーン製品、鋳物、建築、研磨剤で使用される合成樹脂の中間体として使用されるフェノールや誘導体の製造も行っている。さらに、自動車、エレクトロニクス、様々なニッチ化学・工業用途向けにフッ素やレアアース製剤を提供している。同社は1863年に設立され、ベルギーのブリュッセルに本社を置いている。
Solvay SA 基礎のまとめ
| SOLB 基礎統計学 | |
|---|---|
| 時価総額 | €2.91b |
| 収益（TTM） | €30.00m |
| 売上高(TTM) | €4.75b |
97.2x
PER（株価収益率0.6x
P/SレシオSOLB は割高か？
公正価値と評価分析を参照収益と収入
| SOLB 損益計算書（TTM） | |
|---|---|
| 収益 | €4.75b |
| 売上原価 | €3.74b |
| 売上総利益 | €1.00b |
| その他の費用 | €973.00m |
| 収益 | €30.00m |
直近の収益報告
Dec 31, 2025
次回決算日
May 07, 2026
| 一株当たり利益（EPS） | 0.29 |
| グロス・マージン | 21.13% |
| 純利益率 | 0.63% |
| 有利子負債／自己資本比率 | 165.5% |
SOLB の長期的なパフォーマンスは？
過去の実績と比較を見る| Solvay 配当日 | |
|---|---|
| 配当落ち日 | May 18 2026 |
| 配当支払日 | May 20 2026 |
| 配当落ちまでの日数 | 15 days |
| 配当支払日までの日数 | 17 days |
SOLB 配当は確実ですか？
SOLB 配当履歴とベンチマークを見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/03 09:36 |
| 終値 | 2026/04/30 00:00 |
| 収益 | 2025/12/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Solvay SA 11 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。33
| アナリスト | 機関 |
|---|---|
| Robert Bate | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |